13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 17 managers

Reported value

$339.8M

Holders

17

+1 new · −2 exited

Holders’ est. mark

−$48M

Price effect on 11 books still in the name

Largest holder

$253.6M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC483K$253.6M−$35.1MAdded$49.8M
DANSKE BANK A/S50.7K$26.6M−$5.53MCut−$13.6M
PEAK6 LLC37.2K$19.5MHeld
Sanctuary Advisors, LLC33.8K$17.8M−$3.7MCut−$3.88M
OP Asset Management Ltd11.3K$5.96M−$1.24MCut−$1.46M
Swiss Life Asset Management Ltd11.2K$5.86M−$1.14MCut−$740.6K
Pine Valley Investments Ltd Liability Co8.11K$4.26M−$695.3KAdded$221.8K
Leonteq Securities AG4.11K$2.16M−$368.8KCut−$210.8K
Cresset Asset Management, LLC2.8K$1.47MHeld
NWAM LLC1.55K$847.9KHeld
INDEPENDENT FINANCIAL GROUP, LLC1.03K$538.6K−$112.1KCut−$114K
Savant Capital, LLC859$451K−$93.9KCut−$113.6K
Triumph Capital Management843$442.6KHeld
Aventura Private Wealth, LLC428$224.7K−$46.7KCut−$168.5K
ELEVATION POINT WEALTH PARTNERS, LLC113$59.3KNew
Prestige Wealth Management Group LLC87$45.7K−$9.5KCut−$11.4K
Essential Partners LLC8$4.2KHeld

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.